General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Huang LJ et al. - Immunosuppressive agents are used less frequently to treat IBD patients from East China compared with Western countries. Monitoring immunosuppressive agent use is recommended to optimize dispensation of drugs for IBD in China.

Related Articles

IBD drugs and cancer risk
JAMA, 11/18/09    Relevance Score: 87%

Pediatric Inflammatory Bowel Disease: Highlighting Pediatric Differences in IBD
Gastroenterology Clinics of North America, 11/13/09    Relevance Score: 87%

Diagnostic Role and Clinical Association of ASCA and ANCA in Brazilian Patients with Inflammatory Bowel Disease
Digestive Diseases and Sciences, 10/19/09    Relevance Score: 87%

Safety Profile of IBD Therapeutics: Infectious Risks
Gastroenterology Clinics of North America, 11/17/09    Relevance Score: 85%

Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09    Relevance Score: 85%

Today in Inflammatory Bowel Dz...keeping you current

Polymorphisms of the apoptosis-associated gene DP1L1 (deleted in polyposis 1-like 1) in colon cancer and inflammatory bowel disease
Journal of Cancer Research & Clinical Oncology, 12/03/09

Review article: influenza A (H1N1) virus in patients with inflammatory bowel disease
Alimentary Pharmacology and Therapeutics, 12/03/09

chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease
Alimentary Pharmacology and Therapeutics, 12/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address